Experiment set1IT022 for Paraburkholderia graminis OAS925

Compare to:

Citric Acid carbon source

Group: carbon source
Media: RCH2_defined_noCarbon + Citric Acid (20 mM)
Culturing: Burkholderia_OAS925_ML2, 96 deep-well microplate; 0.8 mL volume, Aerobic, at 30 (C), shaken=700 rpm
By: Marta on 10-Apr-21
Media components: 0.25 g/L Ammonium chloride, 0.1 g/L Potassium Chloride, 0.6 g/L Sodium phosphate monobasic monohydrate, 30 mM PIPES sesquisodium salt, Wolfe's mineral mix (0.03 g/L Magnesium Sulfate Heptahydrate, 0.015 g/L Nitrilotriacetic acid, 0.01 g/L Sodium Chloride, 0.005 g/L Manganese (II) sulfate monohydrate, 0.001 g/L Cobalt chloride hexahydrate, 0.001 g/L Zinc sulfate heptahydrate, 0.001 g/L Calcium chloride dihydrate, 0.001 g/L Iron (II) sulfate heptahydrate, 0.00025 g/L Nickel (II) chloride hexahydrate, 0.0002 g/L Aluminum potassium sulfate dodecahydrate, 0.0001 g/L Copper (II) sulfate pentahydrate, 0.0001 g/L Boric Acid, 0.0001 g/L Sodium Molybdate Dihydrate, 0.003 mg/L Sodium selenite pentahydrate), Wolfe's vitamin mix (0.1 mg/L Pyridoxine HCl, 0.05 mg/L 4-Aminobenzoic acid, 0.05 mg/L Lipoic acid, 0.05 mg/L Nicotinic Acid, 0.05 mg/L Riboflavin, 0.05 mg/L Thiamine HCl, 0.05 mg/L calcium pantothenate, 0.02 mg/L biotin, 0.02 mg/L Folic Acid, 0.001 mg/L Cyanocobalamin)

Specific Phenotypes

For 4 genes in this experiment

For carbon source Citric Acid in Paraburkholderia graminis OAS925

For carbon source Citric Acid across organisms

SEED Subsystems

Subsystem #Specific
Alkanesulfonate assimilation 1
Alkanesulfonates Utilization 1
Peptidoglycan Biosynthesis 1
Pyruvate metabolism I: anaplerotic reactions, PEP 1
Type IV pilus 1

Metabolic Maps

Color code by fitness: see overview map or list of maps.

Maps containing gene(s) with specific phenotypes:

MetaCyc Pathways

Pathways that contain genes with specific phenotypes:

Pathway #Steps #Present #Specific
two-component alkanesulfonate monooxygenase 2 2 1
dimethyl sulfide degradation II (oxidation) 5 2 1
peptidoglycan biosynthesis IV (Enterococcus faecium) 17 12 2
peptidoglycan biosynthesis II (staphylococci) 17 12 2
peptidoglycan biosynthesis V (β-lactam resistance) 17 11 2
peptidoglycan biosynthesis I (meso-diaminopimelate containing) 12 12 1
peptidoglycan maturation (meso-diaminopimelate containing) 12 4 1
peptidoglycan biosynthesis III (mycobacteria) 15 11 1